BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ:AKRX) today announced the signing of a development and supply agreement with Hyaluron Contract Manufacturing, Inc. (HCM), an innovative leader in aseptic formulation and filling of liquid parenterals located in Burlington, Massachusetts. The Agreement provided for two ANDA injectable suspension products with a 2006 market size of approximately $220 million, according to IMS sales data.
